SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Fennec Pharmaceuticals Q1 EPS $(0.190) Down From $(0.130) YoY

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.190) per share. This is a 46.15 percent decrease over losses of $(0.130) per share from the same period last year.

Benzinga · 05/14/2020 10:06

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.190) per share. This is a 46.15 percent decrease over losses of $(0.130) per share from the same period last year.